The largest database of trusted experimental protocols

16 protocols using gibson assembly cloning

1

SARS-CoV-2 Nsp1/Nsp2 Expression Plasmids

Check if the same lab product or an alternative is used in the 5 most similar protocols
pLVX-EF1alpha-SARS-CoV-2-Nsp1-2XStrep-IRES-Puro plasmid (Addgene, 141367) and pLVX-EF1alpha-SARS-CoV-2-Nsp2-2XStrep-IRES-Puro plasmid (Addgene, 141368) were obtained from Addgene. The IRES-Puro elements in the above plasmids were replaced with IRES-TagBFP from TRE-KRAB-dCAS9-IRES-BFP (Addgene, 85449) to make them compatible with the MeTAFlow assay. Briefly, IRES-Tag BFP was PCR amplified using oligos in Supplemental File 1. The pLVX-EF1alpha-SARS-CoV-2-Nsp1/Nsp2-2XStrep-IRES-Puro plasmids were digested with BamHI (NEB) and MluI (NEB) to remove the IRES-Puromycin fragment followed by gel purification. The purified vector was ligated with the IRES-TagBFP PCR amplified product using Gibson assembly cloning (NEB). The sequences of the resulting plasmid clones were confirmed by Sanger sequencing.
+ Open protocol
+ Expand
2

EGFP Fusion Receptor Cloning

Check if the same lab product or an alternative is used in the 5 most similar protocols
To generate an EGFP fusion with the receptors, human TfR1 or TfR2 genes were cloned into the pEGFP-N1 expression plasmid (Stratagene; primers listed in Supplemental Table 1). To generate the TfR2-TfR1 helical domain chimera, residues 1–636 of TfR2 were inserted to the 5’ end of residues 605–760 of TfR1 in pEGFP-N1 using Gibson Assembly cloning (New England Biolabs; primers listed in Supplemental Table 1) according to manufacturer’s procedure. Point-mutations were introduced with the Quikchange Lightning site-directed mutagenesis kit (Agilent). All plasmids were verified by Sanger sequencing.
+ Open protocol
+ Expand
3

Plasmid Generation and Cloning

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmids used in this study are indicated in Table 1 and Table S1. Plasmids were generated
using either restriction digest-based cloning or Gibson assembly cloning
[New England Biolabs (NEB)]. In some cases, DNA sequences of
interest were amplified via PCR using the indicated primers and inserted into
the pJET1.2 cloning vector. DNA sequences were subcloned into the pKV363 suicide
vector used for gene deletions, the pKV69 overexpression plasmid, or the pEVS107
mini-Tn7 delivery vector using standard molecular
techniques. Alternatively, sequences were amplified using the indicated primers
and then inserted into a mobilization vector using the Gibson Assembly approach
(NEB). For site-directed mutagenesis of sypF,
sypG, or sypF*, either Gibson
Assembly or the Quick-Change Site-Directed Mutagenesis Kit (Stratagene) with the
primer(s) indicated in Table
S2
was used.
+ Open protocol
+ Expand
4

Versatile Core35S-GFP Construct Engineering

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Core35S-GFP construct was based on pAI101, a binary vector modified from pCambia1300 [28 (link),29 (link)]. An expression cassette consisting of the core 35S promoter (the last 99 nt of the cauliflower mosaic virus (CaMV) 35S promoter), the EGFP cDNA, and the poly-A signal of CaMV 35S RNA was inserted into pAI101 at the PstI site to create Core35S-GFP. The Core35S-GFP construct was then used as the backbone to create constructs in which the Core35S promoter was replaced by the sequences of the MYMV BV1 promoter, its counterpart in the soybean yellow mosaic virus (SYMV), and their mutated derivatives. The corresponding DNA fragments were custom-synthesized by Integrated DNA Technologies (IDT, Coralville, IA, USA) as gBlocks fragments and used to replace the Core35S sequence via Gibson Assembly cloning (New England Biolabs, Ipswich, MA, USA). The AC2-expressing construct was also made in pAI101, in which the AC2 cDNA was preceded by the CaMV 35S promoter with double enhancers (2X35S), plus a translational enhancer derived from the tobacco etch virus (TEV TE) [28 (link),29 (link),30 (link)]. The identity of all constructs was verified with Sanger sequencing.
+ Open protocol
+ Expand
5

Purification of SARS-CoV-2 Variant Antigens

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genes encoding RBD of SARS-CoV-2 Alpha, Beta, Gamma, Delta, and Omicron variants were cloned in-frame into the pcDNA3.4-SARS-CoV-2-spike RBD-his using Gibson Assembly cloning (NEB, Ipswich, MA, USA) [13 (link)]. SARS-CoV-2 antigens were produced in Expi293 cells (Thermo Fisher Scientific) and his–tagged SARS-CoV-2 antigens protein was purified using Ni-NTA agarose resin (Thermo Fisher Scientific) affinity chromatography, as described previously [13 (link)].
After 5 days of transfection, the supernatant was collected and passed over the Ni-NTA agarose resin column three times. First, the column was washed with 100 mL of 1× PBS to remove nonspecific bound proteins. Then, 3 mL of elution buffer (pH8.0, 50 mM sodium phosphate, 300 mM NaCl, and 250 mM imidazole) was added to elute the bound proteins. Finally, samples were buffer-exchanged into pH 7.4 PBS using Amicon Ultra-4 (Merck Millipore, Burlington, MA, USA) spin columns with a 10 kDa cutoff. The purity of purified samples was assessed by 14% SDS-PAGE gel (Additional file 1: Supplementary Fig. 1).
+ Open protocol
+ Expand
6

Generation of Phospho-Mutant FIT Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmids with genomic DNA or complementary DNA (cDNA) sequences for intermediate cloning steps and experiments were generated by PCR, subsequent Gateway (Life Technologies), Gibson assembly cloning (New England Biolabs, Ipswich, MA, USA), or AQUA cloning (Beyer et al., 2015) and verified by sequencing (see list of recombinant plasmids used/constructed in Supporting Information Table S1; primers for plasmid generation are in Table S2). Site‐directed mutagenesis was conducted by PCR with genomic FIT to create phospho‐mutant gFITm forms, namely FITm(S221A), FITm(S221E), FITm(S221E/SS271/272AA), FITm(Y238F), FITm(Y238E), FITm(Y278F), and FITm(Y278E), as described previously (Gratz et al., 2019) for FITm(SS271/272AA). Briefly, methylated template plasmid DNA was eliminated by DpnI treatment before DH5α Escherichia coli transformation. FIT and FITm coding sequences without introns were obtained from cDNA prepared from transiently transformed Nicotiana benthamiana leaves with expression plasmids containing gFIT‐GFP and gFITm‐GFP forms (GFP, green fluorescent protein).
+ Open protocol
+ Expand
7

Genetically Engineered C. parvum Luciferase Strains

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 5’ UTR and 3’UTR of the C. parvum actin gene was amplified from parasite genomic DNA and ligated into KpnI/ClaI and SpeI/BamHI sites of plasmid TK-Eno-Nluc-Neo-TK 8 (link) respectively. The coding sequence for red-shifted luciferase20 (link) was amplified from pTubRE9 vector (kind gift from Markus Meissner, University of Glasgow) and cloned into SalI/NheI restriction sites replacing Nluc. A 404 bp fragment of the 5’TK flank, the tk gene and a ribosomal 3’UTR was inserted upstream of the 5’ actin UTR using Gibson Assembly cloning (New England Biolabs). The final vector, along with the Cas9 plasmid containing a TK guide RNA (GAAGAATACAATTTCTAAGG) that targets the 3’ end of the tk gene was used to transfect C. parvum sporozoites. Sporozoites were delivered via surgery into the small intestine of C57BL/6 IFN-γ knockout mice (B6.129S7-Ifngtm1Ts/J, Jackson Laboratories) using procedures described previously8 (link). Note that UGA1 Nluc parasites were generated using C. parvum IOWA II oocysts purchased from Sterling Parasitology Laboratory, University of Arizona whereas the UGA2 Fluc strain was engineered using C. parvum IOWA II oocysts purchased from Bunch Grass Farms, Deary, ID.
+ Open protocol
+ Expand
8

Genetic engineering of C. parvum reporter strains

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 5′ untranslated region (UTR) and 3′ UTR of the C. parvum actin gene were amplified from parasite genomic DNA and ligated into the KpnI/ClaI and SpeI/BamHI sites of plasmid TK-Eno-Nluc-Neo-TK8 (link), respectively. The coding sequence for red-shifted luciferase20 (link) was amplified from pTubRE9 vector (a gift from M. Meissner, University of Glasgow, UK) and cloned into SalI/NheI restriction sites replacing Nluc. A 404-base-pair fragment of the 5′ TK flank, the tk gene, and a ribosomal 3′ UTR were inserted upstream of the 5′ actin UTR using Gibson Assembly cloning (New England Biolabs). The final vector, along with the Cas9 plasmid containing a TK guide RNA (GAAGAATACAATTTCTAAGG) targeting the 3′ end of the tk gene, was used to transfect C. parvum sporozoites. Sporozoites were delivered by surgery into the small intestine of C57BL/6 IFN-γ knockout mice (B6.129S7-Ifngtm1Ts/J, Jackson Laboratory) using procedures described previously8 (link). Note that UGA1 Nluc parasites were generated using C. parvum IOWA II oocysts purchased from Sterling Parasitology Laboratory, University of Arizona, whereas the UGA2 Fluc strain was engineered using C. parvum IOWA II oocysts purchased from Bunch Grass Farms, Deary, Idaho, USA.
+ Open protocol
+ Expand
9

SARS-CoV-2 Nsp1/Nsp2 Expression Plasmids

Check if the same lab product or an alternative is used in the 5 most similar protocols
pLVX-EF1alpha-SARS-CoV-2-Nsp1–2XStrep-IRES-Puro plasmid (Addgene, 141367) and pLVX-EF1alpha-SARS-CoV-2-Nsp2–2XStrep-IRES-Puro plasmid (Addgene, 141368) were obtained from Addgene. The IRES-Puro elements in the above plasmids were replaced with IRES-TagBFP from TRE-KRAB-dCAS9-IRES-BFP (Addgene, 85449) to make them compatible with the MeTAFlow assay. Briefly, IRES-Tag BFP was PCR amplified using oligos in Supplementary file 1. The pLVX-EF1alpha-SARS-CoV-2-Nsp1/Nsp2–2XStrep-IRES-Puro plasmids were digested with BamHI (NEB) and MluI (NEB) to remove the IRES-Puromycin fragment followed by gel purification. The purified vector was ligated with the IRES-TagBFP PCR amplified product using Gibson assembly cloning (NEB). The sequences of the resulting plasmid clones were confirmed by Sanger sequencing.
+ Open protocol
+ Expand
10

Construction and Characterization of pwin3.12-OxO Plasmid

Check if the same lab product or an alternative is used in the 5 most similar protocols
A vector (Figure 1) containing win3.12 promoter was constructed starting from the previously used CaMV35S‐OxO construct containing OxO driven by CaMV 35S promoter with ACT2 terminator (from A. thaliana), along with NPTII antibiotic selection gene (Zhang et al., 2013 (link)). The CaMV 35S promoter was removed via restriction digest and replaced with the win3.12 promoter via Gibson assembly cloning (New England Biolabs). The new vector was designated pwin3.12‐OxO. The pwin3.12‐OxO plasmid's promoter and coding region were sequenced via Sanger sequencing (SUNY Upstate Molecular Analysis Core Facility, Syracuse, NY, USA). The pwin3.12‐OxO plasmid was transformed into Agrobacterium tumefaciens EHA105 using electroporation for future C. dentata embryo transformations.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!